{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05040373",
            "orgStudyIdInfo": {
                "id": "ALN-TTR02-010"
            },
            "organization": {
                "fullName": "Alnylam Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program",
            "officialTitle": "Patisiran-LNP Pregnancy Surveillance Program",
            "therapeuticArea": [
                "Neurology",
                "Other"
            ],
            "study": "patisiran-lipid-nanoparticle-lnp-pregnancy-surveillance-program"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-08-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2030-10-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-10-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-07-14",
            "studyFirstSubmitQcDate": "2021-09-07",
            "studyFirstPostDateStruct": {
                "date": "2021-09-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-18",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-19",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Alnylam Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to collect and evaluate pregnancy outcomes, pregnancy complications, and fetal/neonatal/infant outcomes in women exposed to patisiran-LNP."
        },
        "conditionsModule": {
            "conditions": [
                "Hereditary Transthyretin-mediated (hATTR) Amyloidosis",
                "Polyneuropathy"
            ],
            "keywords": [
                "Hereditary neuropathic amyloidosis",
                "Familial amyloidosis",
                "Amyloidosis",
                "Amyloidosis senile",
                "Cardiac amyloidosis"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Patisiran",
                    "description": "Pregnant women exposed to commercial patisiran-LNP (ONPATTRO) during the 12 weeks prior to their last menstrual period (LMP) or at any time during pregnancy."
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Prevalence of Major Congenital Malformations",
                    "description": "Major congenital malformations will be classified according to the European Concerted Action on Congenital Anomalies and Twins (EUROCAT) and Metropolitan Atlanta Congenital Defects Program (MACDP) classification systems.",
                    "timeFrame": "From 12 weeks prior to last dose of patisiran through one year after birth (Up to 21 months)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Prevalence of Minor Congenital Malformations",
                    "description": "Minor congenital malformations will be classified classified according to the EUROCAT and MACDP classification systems.",
                    "timeFrame": "From 12 weeks prior to last dose of patisiran through one year after birth (Up to 21 months)"
                },
                {
                    "measure": "Prevalence of Pregnancy Outcomes",
                    "description": "Pregnancy outcomes are defined as live birth, spontaneous abortions, stillbirths, elective abortions, molar or pregnancy, ectopic pregnancy, preterm births, and maternal death.",
                    "timeFrame": "From 12 weeks prior to last dose of patisiran through one year after birth (Up to 21 months)"
                },
                {
                    "measure": "Prevalence of Other Adverse Fetal/Neonatal/Infant Outcomes",
                    "description": "Other adverse fetal/neonatal/infant outcomes are defined as low birth weight, failure to thrive, small for gestational age, postnatal growth and development, neonatal, and perinatal, or infant death.",
                    "timeFrame": "From 12 weeks prior to last dose of patisiran through one year after birth (Up to 21 months)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Documentation that the patient was exposed to patisiran-LNP at any point starting from 12 weeks before LMP or at any point during pregnancy\n\nExclusion Criteria:\n\n* There are no exclusion criteria for participation in this program.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Any woman exposed to patisiran-LNP 12 weeks prior to their last menstrual period (LMP) or at any time during pregnancy.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Alnylam Clinical Trial Information Line",
                    "role": "CONTACT",
                    "phone": "1-877-ALNYLAM",
                    "email": "clinicaltrials@alnylam.com"
                },
                {
                    "name": "Alnylam Clinical Trial Information Line",
                    "role": "CONTACT",
                    "phone": "1-877-256-9526",
                    "email": "clinicaltrials@alnylam.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Alnylam Pharmaceuticals",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Clinical Trial Site",
                    "status": "RECRUITING",
                    "city": "Iowa City",
                    "state": "Iowa",
                    "zip": "52242",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.66113,
                        "lon": -91.53017
                    }
                },
                {
                    "facility": "Clinical Trial Site",
                    "status": "RECRUITING",
                    "city": "Nantes",
                    "country": "France",
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "Clinical Trial Site",
                    "status": "RECRUITING",
                    "city": "M\u00fcnster",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.96236,
                        "lon": 7.62571
                    }
                },
                {
                    "facility": "Clinical Trial Site",
                    "status": "RECRUITING",
                    "city": "Pavia",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.19205,
                        "lon": 9.15917
                    }
                },
                {
                    "facility": "Clinical Trial Site",
                    "status": "RECRUITING",
                    "city": "Groningen",
                    "country": "Netherlands",
                    "geoPoint": {
                        "lat": 53.21917,
                        "lon": 6.56667
                    }
                },
                {
                    "facility": "Clinical Trial Site",
                    "status": "RECRUITING",
                    "city": "Lisboa",
                    "country": "Portugal",
                    "geoPoint": {
                        "lat": 38.71667,
                        "lon": -9.13333
                    }
                },
                {
                    "facility": "Clinical Trial Site",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011115",
                    "term": "Polyneuropathies"
                },
                {
                    "id": "D000000686",
                    "term": "Amyloidosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000057165",
                    "term": "Proteostasis Deficiencies"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000010523",
                    "term": "Peripheral Nervous System Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4021",
                    "name": "Amyloidosis",
                    "asFound": "Amyloidosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13999",
                    "name": "Polyneuropathies",
                    "asFound": "Polyneuropathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M23330",
                    "name": "Amyloid Neuropathies, Familial",
                    "relevance": "LOW"
                },
                {
                    "id": "M23329",
                    "name": "Amyloidosis, Familial",
                    "relevance": "LOW"
                },
                {
                    "id": "M28747",
                    "name": "Proteostasis Deficiencies",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13432",
                    "name": "Peripheral Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2733",
                    "name": "Hereditary Amyloidosis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}